179 related articles for article (PubMed ID: 20213825)
1. Impulsive-compulsive spectrum behaviors in pathologically confirmed progressive supranuclear palsy.
O'Sullivan SS; Djamshidian A; Ahmed Z; Evans AH; Lawrence AD; Holton JL; Revesz T; Lees AJ
Mov Disord; 2010 Apr; 25(5):638-42. PubMed ID: 20213825
[TBL] [Abstract][Full Text] [Related]
2. Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease.
Fenu S; Wardas J; Morelli M
Behav Pharmacol; 2009 Sep; 20(5-6):363-79. PubMed ID: 19724195
[TBL] [Abstract][Full Text] [Related]
3. Impulsive and compulsive behaviors in Parkinson's disease: a one-year follow-up study.
Ávila A; Cardona X; Martín-Baranera M; Bello J; Sastre F
J Neurol Sci; 2011 Nov; 310(1-2):197-201. PubMed ID: 21683375
[TBL] [Abstract][Full Text] [Related]
4. Clinical aspects of impulsive compulsive behaviours in Parkinson's disease.
Djamshidian A; Averbeck BB; Lees AJ; O'Sullivan SS
J Neurol Sci; 2011 Nov; 310(1-2):183-8. PubMed ID: 21839478
[TBL] [Abstract][Full Text] [Related]
5. [Dopamine dysregulation syndrome in Parkinson's disease and restless legs syndrome].
Bayard S; Cochen De Cock V; Dauvillers Y
Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):227-35. PubMed ID: 21690031
[TBL] [Abstract][Full Text] [Related]
6. Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease.
Lee JY; Kim JM; Kim JW; Cho J; Lee WY; Kim HJ; Jeon BS
Parkinsonism Relat Disord; 2010 Mar; 16(3):202-7. PubMed ID: 20018549
[TBL] [Abstract][Full Text] [Related]
7. Excessive dopamine neuron loss in progressive supranuclear palsy.
Murphy KE; Karaconji T; Hardman CD; Halliday GM
Mov Disord; 2008 Mar; 23(4):607-10. PubMed ID: 18163454
[TBL] [Abstract][Full Text] [Related]
8. The relationship between impulsivity and impulse control disorders in Parkinson's disease.
Isaias IU; Siri C; Cilia R; De Gaspari D; Pezzoli G; Antonini A
Mov Disord; 2008 Feb; 23(3):411-5. PubMed ID: 18067187
[TBL] [Abstract][Full Text] [Related]
9. Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies.
Hassan A; Bower JH; Kumar N; Matsumoto JY; Fealey RD; Josephs KA; Ahlskog JE
Parkinsonism Relat Disord; 2011 May; 17(4):260-4. PubMed ID: 21310646
[TBL] [Abstract][Full Text] [Related]
10. [Impulsive-compulsive syndrome in Parkinson's disease].
Nikitina AV; Fedorova NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7 Pt 2):32-8. PubMed ID: 23994929
[TBL] [Abstract][Full Text] [Related]
11. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
12. Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management.
Ceravolo R; Frosini D; Rossi C; Bonuccelli U
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S111-5. PubMed ID: 20123548
[TBL] [Abstract][Full Text] [Related]
13. Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease.
Lim SY; O'Sullivan SS; Kotschet K; Gallagher DA; Lacey C; Lawrence AD; Lees AJ; O'Sullivan DJ; Peppard RF; Rodrigues JP; Schrag A; Silberstein P; Tisch S; Evans AH
J Clin Neurosci; 2009 Sep; 16(9):1148-52. PubMed ID: 19553125
[TBL] [Abstract][Full Text] [Related]
14. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata.
Hardman CD; Halliday GM; McRitchie DA; Cartwright HR; Morris JG
Exp Neurol; 1997 Mar; 144(1):183-92. PubMed ID: 9126169
[TBL] [Abstract][Full Text] [Related]
15. Compulsive eating and weight gain related to dopamine agonist use.
Nirenberg MJ; Waters C
Mov Disord; 2006 Apr; 21(4):524-9. PubMed ID: 16261618
[TBL] [Abstract][Full Text] [Related]
16. Pathological hypersexuality induced by dopamine replacement therapy in a patient with progressive supranuclear palsy.
Kim YY; Park HY; Kim JM; Kim KW
J Neuropsychiatry Clin Neurosci; 2008; 20(4):496-7. PubMed ID: 19196941
[No Abstract] [Full Text] [Related]
17. Impulse control disorders in patients with Parkinson's disease.
Gescheidt T; Bares M
Acta Neurol Belg; 2011 Mar; 111(1):3-9. PubMed ID: 21510226
[TBL] [Abstract][Full Text] [Related]
18. Impulse control disorders and punding in Parkinson's disease: the need for a structured interview.
Ávila A; Cardona X; Bello J; Maho P; Sastre F; Martín-Baranera M
Neurologia; 2011 Apr; 26(3):166-72. PubMed ID: 21163239
[TBL] [Abstract][Full Text] [Related]
19. Drug Insight: impulse control disorders and dopamine therapies in Parkinson's disease.
Potenza MN; Voon V; Weintraub D
Nat Clin Pract Neurol; 2007 Dec; 3(12):664-72. PubMed ID: 18046439
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced impulse control disorders in Parkinson's disease.
Reiff J; Jost WH
J Neurol; 2011 May; 258(Suppl 2):S323-7. PubMed ID: 21560063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
